Cargando…

Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients

BACKGROUND: Adrenocortical carcinoma (ACC) is a rare malignant endocrine tumour. Due to a high tumour recurrence rate, the post-operative overall survival (OS) and disease-free survival (DFS) of ACCs is limited. Our research aims to identify the role of the epithelial-mesenchymal transition (EMT) re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Jiayu, Liu, Zhihong, Wei, Xin, Zhou, Liang, Tang, Yongquan, Zhou, Chuan, Wu, Kan, Zhang, Fuxun, Zhang, Fan, Lu, Yiping, Zhu, Yuchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884893/ https://www.ncbi.nlm.nih.gov/pubmed/31783819 http://dx.doi.org/10.1186/s12885-019-6389-3

Ejemplares similares

Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study
por: Zhang, Fuxun, et al.
Publicado: (2021)

Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma
por: Liang, Jiayu, et al.
Publicado: (2020)

Reoperation for Recurrent Adrenocortical Carcinoma: A Systematic Review and Pooled Analysis of Population-Based Studies
por: Zhang, Fan, et al.
Publicado: (2022)

Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
por: Tang, Yongquan, et al.
Publicado: (2018)

Expression of glucocorticoid receptor (GR) and clinical significance in adrenocortical carcinoma
por: Wu, Kan, et al.
Publicado: (2022)

Early post-operative serum albumin level predicts survival after curative nephrectomy for kidney cancer: a retrospective study
por: Tang, Yongquan, et al.
Publicado: (2018)

Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth in vitro and in vivo
por: Liang, Jiayu, et al.
Publicado: (2019)

Discovery of a glucocorticoid receptor (GR) activity signature correlates with immune cell infiltration in adrenocortical carcinoma
por: Wu, Kan, et al.
Publicado: (2023)

The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer
por: Liang, Jiayu, et al.
Publicado: (2018)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma
por: Chen, Yue, et al.
Publicado: (2019)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021)

FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer
por: Tang, Qingyun, et al.
Publicado: (2022)

The Role of CD276 in Cancers
por: Liu, Shengzhuo, et al.
Publicado: (2021)

OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer
por: Wang, Yiqin, et al.
Publicado: (2016)

Significance of BMI1 and FSCN1 Expression in Colorectal Cancer
por: Alajez, Nehad M.
Publicado: (2016)

Prognostic significance of FSCN family in multiple myeloma
por: Deng, Cong, et al.
Publicado: (2021)

FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma
por: Li, Peipei, et al.
Publicado: (2023)

FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017)

Clinical significance of prognostic nutritional index in renal cell carcinomas
por: Tang, Yongquan, et al.
Publicado: (2021)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Expression of FOXM1 and PLK1 predicts prognosis of patients with hepatocellular carcinoma
por: Fan, Weiqiang, et al.
Publicado: (2022)

SOX2 Promotes Brain Metastasis of Breast Cancer by Upregulating the Expression of FSCN1 and HBEGF
por: Xiao, Weikai, et al.
Publicado: (2020)

miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion
por: Liu, Yanping, et al.
Publicado: (2017)

The role of microRNA-133b and its target gene FSCN1 in gastric cancer
por: Guo, Lihua, et al.
Publicado: (2014)

Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer
por: Ou, Chunlin, et al.
Publicado: (2019)

FSCN-1 increases doxorubicin resistance in hepatocellular carcinoma through promotion of epithelial-mesenchymal transition
por: Zhang, Yuanbiao, et al.
Publicado: (2018)

FoxM1 Is Associated with Poor Prognosis of Non-Small Cell Lung Cancer Patients through Promoting Tumor Metastasis
por: Xu, Nuo, et al.
Publicado: (2013)

Targeting FSCN1 with an oral small-molecule inhibitor for treating ocular neovascularization
por: Bai, Wen, et al.
Publicado: (2023)

LYAR Promotes Colorectal Cancer Progression by Upregulating FSCN1 Expression and Fatty Acid Metabolism
por: Wu, Yupeng, et al.
Publicado: (2021)

Correction to: The role of microRNA-133b and its target gene FSCN1 in gastric cancer
por: Guo, Lihua, et al.
Publicado: (2020)

Circ-FOXM1 promotes the proliferation, migration and EMT process of osteosarcoma cells through FOXM1-mediated Wnt pathway activation
por: Zhang, Hao, et al.
Publicado: (2022)

EGFR conjunct FSCN1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
por: Wang, Chao-Qun, et al.
Publicado: (2017)

Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
por: Wen, Ning, et al.
Publicado: (2014)

miR-145 Contributes to the Progression of Cervical Carcinoma by Directly Regulating FSCN1
por: Ma, Li, et al.
Publicado: (2019)

FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration
por: Li, Sisi, et al.
Publicado: (2021)

Comprehensive analysis of the expression, prognosis and biological significance of FSCN family in clear cell renal cell carcinoma
por: Lin, Yongping, et al.
Publicado: (2023)

FoxM1 overexpression promotes cell proliferation and migration and inhibits apoptosis in hypopharyngeal squamous cell carcinoma resulting in poor clinical prognosis
por: Chen, Yan, et al.
Publicado: (2017)

Transcriptome analysis reveals the potential biological function of FSCN1 in HeLa cervical cancer cells
por: Guo, Fengqin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4cub4b4ijjqeqm6dgqv2ah2jlk